Although the impact of TAZ knockout on the phenotypes of kidney and lung maturation in mice needs to be considered, the development of anticancer drugs targeting TAZ may be effective in treating cancers that strongly express TAZ carrying wild-type p53. This evidence concerns the gene TP53 and cancer.